Pontus Protein Ltd
XTSX:HULK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.2), the stock would be worth CA$0.01 (0% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.2 | CA$0.01 |
0%
|
| 3-Year Average | 0.2 | CA$0.01 |
0%
|
| 5-Year Average | 0.2 | CA$0.01 |
0%
|
| Industry Average | 4.3 | CA$0.09 |
+1 630%
|
| Country Average | 2.7 | CA$0.05 |
+978%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
P
|
Pontus Protein Ltd
XTSX:HULK
|
486.5k CAD | 0.2 | -0.1 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
308.8B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 1 319.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
101.6B ZAR | 1.1 | 10.5 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.5B USD | 1 973.5 | 38 690 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
55.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.1B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
32.4B EUR | 7.8 | 174.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 53.7 | -3 284.6 | |
| US |
Q
|
Qnity Electronics Inc
NYSE:Q
|
30.3B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.9 |
| Max | 1 402.4 |
Other Multiples
Pontus Protein Ltd
Glance View
Pontus Protein Ltd. engages in the making of plant-based protein powder sourced from nutritious water lentils. The company is headquartered in Surrey, British Columbia. The company went IPO on 2019-05-21. The firm is primarily focused on production of organic plant-based protein products. Pontus specializes in aquaponic farming through the employment of its closed environment vertical aquaponics system (CEVAS), a network of automated bio-secure indoor aquaponic farms utilizing artificial intelligence (AI), to produce non-genetically modified organism (GMO), organic plant-based protein product called Pontus Protein Powder. Pontus Protein Powder is designed to be added to enhance the nutrition profile of food and drinks, at home or for food producers. Its water lentils are grown without the use of solvents, chemicals, dyes, additives, preservatives or pesticides. The firm sells its products through retail, wholesale and online channels.
